O
OrbiMed’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-227,600
| Closed | -$16.5M | – | 146 |
|
|
2022
Q1 | $16.5M | Buy |
+227,600
| New | +$16.5M | 0.27% | 76 |
|
|
2019
Q4 | – | Sell |
-834,313
| Closed | -$35.7M | – | 137 |
|
|
2019
Q3 | $35.7M | Buy |
834,313
+754,706
| +948% | +$32.3M | 0.68% | 45 |
|
|
2019
Q2 | $5.06M | Buy |
+79,607
| New | +$5.06M | 0.08% | 104 |
|
|
2018
Q3 | – | Sell |
-67,605
| Closed | -$5.2M | – | 154 |
|
|
2018
Q2 | $5.2M | Buy |
+67,605
| New | +$5.2M | 0.06% | 124 |
|
|
2017
Q1 | – | Sell |
-169,300
| Closed | -$11.9M | – | 136 |
|
|
2016
Q4 | $11.9M | Hold |
169,300
| – | – | 0.15% | 84 |
|
|
2016
Q3 | $12M | Hold |
169,300
| – | – | 0.14% | 92 |
|
|
2016
Q2 | $8.28M | Buy |
169,300
+41,000
| +32% | +$2.01M | 0.09% | 96 |
|
|
2016
Q1 | $8.12M | Buy |
+128,300
| New | +$8.12M | 0.09% | 101 |
|